a u.s. federal appeals court ruled 15 september 2009 that mircera infringes a patent held by amgen inc. the court refused to lift an injunction entered in the fall of 2008 which barred roche from selling mircera in the united states. however, the injunction has since expired and mircera is available on the us market since 2015.